CN Patent

CN112656761B — 一种低刺激性阿立哌唑前药的油溶缓释注射制剂及其制备方法

Assigned to Henan Hezhi Pharmaceutical Technology Co ltd · Expires 2023-09-08 · 3y expired

What this patent protects

本发明公开了一种低刺激性阿立哌唑前药的油溶缓释注射制剂，含有式Ⅰ表示的化合物、或其药学上可接受的盐，和苯甲酸苄酯，和注射用油。本发明还一种低刺激性阿立哌唑前药的油溶缓释注射制剂的制备方法。制备工艺简单、无需粒径控制、无菌保证水平好、生物利用度高、缓释效果好，刺激性低的特点。

USPTO Abstract

本发明公开了一种低刺激性阿立哌唑前药的油溶缓释注射制剂，含有式Ⅰ表示的化合物、或其药学上可接受的盐，和苯甲酸苄酯，和注射用油。本发明还一种低刺激性阿立哌唑前药的油溶缓释注射制剂的制备方法。制备工艺简单、无需粒径控制、无菌保证水平好、生物利用度高、缓释效果好，刺激性低的特点。

Drugs covered by this patent

Patent Metadata

Patent number
CN112656761B
Jurisdiction
CN
Classification
—
Expires
2023-09-08
Drug substance claim
No
Drug product claim
No
Assignee
Henan Hezhi Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.